127 related articles for article (PubMed ID: 8688334)
1. A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.
Speiser P; Gharehbaghi-Schnell E; Eder S; Haid A; Kovarík J; Nenutil R; Sauter G; Schneeberger CH; Vojtesek B; Wiltschke CH; Zeillinger R
Br J Cancer; 1996 Jul; 74(2):269-73. PubMed ID: 8688334
[TBL] [Abstract][Full Text] [Related]
2. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.
Eeles RA; Warren W; Knee G; Bartek J; Averill D; Stratton MR; Blake PR; Tait DM; Lane DP; Easton DF
Oncogene; 1993 May; 8(5):1269-76. PubMed ID: 8479749
[TBL] [Abstract][Full Text] [Related]
3. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
5. A novel p53 germline alteration identified in a late onset breast cancer kindred.
Sun XF; Johannsson O; Håkansson S; Sellberg G; Nordenskjöld B; Olsson H; Borg A
Oncogene; 1996 Jul; 13(2):407-11. PubMed ID: 8710380
[TBL] [Abstract][Full Text] [Related]
6. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
[TBL] [Abstract][Full Text] [Related]
7. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations.
Mazoyer S; Lalle P; Moyret-Lalle C; Marçais C; Schraub S; Frappaz D; Sobol H; Ozturk M
Oncogene; 1994 Apr; 9(4):1237-9. PubMed ID: 8134127
[TBL] [Abstract][Full Text] [Related]
8. Microdissection as a means to verify allelic imbalance in tumour biology samples.
Speiser P; Gharehbaghi-Schnell E; Schneeberger C; Eder S; Zeillinger R
Anticancer Res; 1996; 16(1):461-4. PubMed ID: 8615654
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
Tomlinson GE; Chen TT; Stastny VA; Virmani AK; Spillman MA; Tonk V; Blum JL; Schneider NR; Wistuba II; Shay JW; Minna JD; Gazdar AF
Cancer Res; 1998 Aug; 58(15):3237-42. PubMed ID: 9699648
[TBL] [Abstract][Full Text] [Related]
10. Point mutations and allelic loss in the TP53 locus of cutaneous malignant melanomas.
Weiss J; Cavenee WK; Herbst RA; Jung EG; Arden KC
Arch Dermatol Res; 1994; 286(7):417-9. PubMed ID: 7818283
[No Abstract] [Full Text] [Related]
11. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
12. Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?
Martin AM; Kanetsky PA; Amirimani B; Colligon TA; Athanasiadis G; Shih HA; Gerrero MR; Calzone K; Rebbeck TR; Weber BL
J Med Genet; 2003 Apr; 40(4):e34. PubMed ID: 12676907
[No Abstract] [Full Text] [Related]
13. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.
Sedlacek Z; Kodet R; Kriz V; Seemanova E; Vodvarka P; Wilgenbus P; Mares J; Poustka A; Goetz P
Br J Cancer; 1998 Apr; 77(7):1034-9. PubMed ID: 9569035
[TBL] [Abstract][Full Text] [Related]
14. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
Tavassoli M; Steingrimsdottir H; Pierce E; Jiang X; Alagoz M; Farzaneh F; Campbell IG
Br J Cancer; 1996 Jul; 74(1):115-9. PubMed ID: 8679443
[TBL] [Abstract][Full Text] [Related]
16. Three germline mutations in the TP53 gene.
Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
MacGeoch C; Turner G; Bobrow LG; Barnes DM; Bishop DT; Spurr NK
J Med Genet; 1995 Mar; 32(3):186-90. PubMed ID: 7783166
[TBL] [Abstract][Full Text] [Related]
18. Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma.
Metzger AK; Sheffield VC; Duyk G; Daneshvar L; Edwards MS; Cogen PH
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7825-9. PubMed ID: 1679237
[TBL] [Abstract][Full Text] [Related]
19. Primitive neuroectodermal tumors of the cerebral hemispheres in two siblings with TP53 germline mutation.
Reifenberger J; Janssen G; Weber RG; Boström J; Engelbrecht V; Lichter P; Borchard F; Göbel U; Lenard HG; Reifenberger G
J Neuropathol Exp Neurol; 1998 Feb; 57(2):179-87. PubMed ID: 9600210
[TBL] [Abstract][Full Text] [Related]
20. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
Pötzsch C; Voigtländer T; Lübbert M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
